| Firm | Analyst |
|---|---|
|
Baird
|
Vikram Kesavabhotla |
|
Bank of America
|
Michael Cherny |
|
Barclays
|
Steve Valiquette / Ross Sandler |
|
Citi
|
Daniel Grosslight |
|
Cowen
|
Charles Rhyee |
|
Credit Suisse
|
Jonathan Yong |
|
DA Davidson
|
Robert Simmons |
|
Deutsche Bank
|
George Hill / Lee Horowitz |
|
Evercore ISI
|
Mark Mahaney |
|
Goldman Sachs
|
Eric Sheridan |
|
Guggenheim
|
Sandy Draper |
|
Jefferies
|
Glen Santangelo |
|
J.P. Morgan
|
Douglas Anmuth |
|
KeyBanc
|
Scott Schoenhaus |
|
Morgan Stanley
|
Craig Hettenbach |
|
Raymond James
|
John Ransom |
|
RBC
|
Sean Dodge |
|
SVB Leerink
|
Stephanie Davis |
|
Truist
|
Jailendra Singh |
|
UBS
|
Kevin Caliendo |
|
Wells Fargo
|
Stan Berenshteyn |
GoodRx is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding GoodRx's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of GoodRx or its management. GoodRx does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.